PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have earned an average rating of “Moderate Buy” from the fifteen analysts that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, eight have assigned a buy rating and one has […]
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have earned an average rating of “Moderate Buy” from the fifteen analysts that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, eight have assigned a buy rating and one has […]
